Skip to content
You can now search across every topic, entity and event.What's new
UK Startups and Innovation
4JUL

UK Horizon Europe share rebounds to 9.3%

3 min read
11:24UTC

DSIT data published on 5 June show the UK's Horizon Europe funding share rose to 9.3% in 2024 from 5.8% a year earlier, with the applied-research strand up 68%, a genuine recovery that still sits below the pre-Brexit peak.

TechnologyDeveloping
Key takeaway

UK Horizon Europe recovery is real and feeds the spinout pipeline, but sits below the 2018/19 peak.

DSIT published UK participation figures for the EU's Horizon Europe research programme on Friday 5 June. The UK's share of funding won rose to 9.3% in 2024, from 5.8% in 2023, worth €994m, with its share of proposals climbing from 18.9% to 24.1%. The department described the result as a partial recovery toward late Horizon 2020 levels, still below the 2018/19 peak. 1

Horizon Europe is the EU's flagship research programme; the UK re-associated in 2024 after Brexit exclusion. The sharpest move sits in Pillar 2, the strand funding industrial and applied collaborative research that feeds university tech-transfer offices and spinouts. The UK's Pillar 2 share rose 68% year on year, from 3.7% to 6.2%. The part of the recovery most likely to surface later as commercial IP is also the part growing fastest.

DSIT's own framing keeps the ceiling in view. Re-association has reopened the collaborative-funding pipe, but it is not yet running at pre-Brexit volume. The France science alliance signed in May is the bilateral hedge that runs alongside the multilateral programme, a second channel for the same collaborative research while Horizon participation climbs back toward where it was.

Deep Analysis

In plain English

Horizon Europe is the European Union's main research funding programme, with a total budget of roughly €95bn for 2021-2027. The UK was excluded from it after Brexit until re-association in early 2024. In 2023, the UK's share of Horizon funding was 5.8%. In 2024, it recovered to 9.3%, meaning UK researchers won €994m of grants. The applied-research strand (Pillar 2) recovered fastest, growing 68% year-on-year. However, DSIT itself describes this as a partial recovery: before Brexit, the UK had a larger share. Getting back to pre-Brexit levels requires winning a higher proportion of the proposals that UK researchers are submitting, which depends partly on Brussels relationships that were disrupted during three years of exclusion.

Deep Analysis
Root Causes

Pillar 2 (industrial research consortia) recovered faster than Pillar 1 (curiosity-driven ERC) for structural reasons. Pillar 2 projects involve industrial consortia where UK companies remain commercially attractive partners regardless of political status. A German automotive manufacturer running a battery electrolyte consortium has direct commercial reasons to include a UK material-science team even under associate rules.

ERC individual grants differ: UK researchers compete head-to-head against EU nationals in peer-review panels where the 2021-2023 exclusion period broke the informal network ties that referees use to assess applicants. Rebuilding those networks takes the length of a grant cycle, roughly 5-7 years, which is why the Pillar 1 recovery lags.

What could happen next?
  • Consequence

    Pillar 2 grants awarded in 2024 will produce commercial IP and spinout companies in 2029-2032. The 68% year-on-year growth means the UK spinout pipeline from Horizon is growing again after a four-year gap.

  • Risk

    The UK's 24.1% proposal share suggests strong research intent but a still-recovering award conversion rate. If consortium-formation biases persist, the actual funding return may plateau before recovering to pre-Brexit levels.

First Reported In

Update #7 · OQC's £260m sets European quantum record

UK Tech News· 7 Jun 2026
Read original
Causes and effects
This Event
UK Horizon Europe share rebounds to 9.3%
The 68% jump in Pillar 2 is a leading indicator for future UK tech transfer and spinout volume, rather than a diplomatic recovery metric.
Different Perspectives
Institute of Physics
Institute of Physics
The Institute has long argued STFC's national-laboratory infrastructure, not its grant programmes, is the binding constraint on UK physics output, and warns mothballing capacity like Clara removes capability that cannot be rebuilt on a four-year cycle. It represents the discovery-science community absorbing the reallocation the Bank's equity cheques do not touch.
Helsing
Helsing
The Munich-headquartered defence-AI firm chose Plymouth over Continental sites for a £350m manufacturing plant building underwater surveillance gliders, alongside its record raise. Its choice of postcode signals confidence in UK manufacturing capacity for defence hardware even as it looks abroad for the capital financing that hardware.
Dragoneer Investment Group, Lightspeed Venture Partners and Iconiq
Dragoneer Investment Group, Lightspeed Venture Partners and Iconiq
The three US growth-capital firms backed Helsing's $1.8bn round at an $18bn valuation, more than doubling the mark set only a year earlier, with demand reportedly exceeding the capital on offer. Their money, not a UK sovereign vehicle, is what funds the Plymouth plant, extending a pattern of foreign capital underwriting British defence-hardware manufacturing this cycle.
British Business Bank
British Business Bank
The Bank wrote its largest-ever direct life-sciences cheque into Alchemab and added a £6.5bn SME lending guarantee the same week UKRI confirmed the STFC cuts. It is deploying an April mandate change letting it lead venture rounds and invest directly up to £60m per company, treating equity extension rounds and small-business debt as newly within its risk appetite.
Daphni
Daphni
The Paris seed fund joined Speedinvest and three UK backers in Astral Systems' GBP23m Series A for modular fusion reactors, one of the round's five European co-investors betting on lab-to-market fusion ahead of any working commercial reactor. Unlike CuspAI's all-foreign cap table, this round kept a UK lead investor in Mercia Ventures.
EQT
EQT
EQT, appointed by the European Innovation Council to run the EUR5bn Scaleup Europe Fund, entered advanced talks for a further CuspAI stake reported on 3 July, the fund's first pursuit of a UK-founded winner. A closed deal would put EU sovereign capital, not a UK vehicle, on the cap table of a company Britain's own funds passed over.